ReviewScience advances2025
Advances in machine learning-enhanced microfluidic cell sorting.
Review in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Review
- Engineered Neutrophils in Translational Medicine: Gene Editing, Nanotechnology, and AI-Driven Clinical Breakthroughs.Advanced healthcare materials · 2026Review
- Tumor organoids as a revolutionary platform for advancing cancer nanomedicine.Molecular cancer · 2026Review
- Integrated Microfluidic Chip Enabling Preparation and Immobilization of Cell-Laden Microspheres, and Microsphere-Based Cell Culture and Analysis.Biosensors · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cell sorting, essential for diagnostics and early intervention, has evolved from conventional methods to sophisticated microfluidic approaches. These miniaturized systems leverage precise hydrodynamic control, facilitating major advances in tumor cell isolation, single-cell analysis, and biomarker detection. However, the vast imaging data generated by these microfluidic techniques necessitate advanced computational methods. Machine learning, particularly computer vision and deep learning, now offers transformative capabilities for automated feature extraction, pattern recognition, and real-time classification, enhancing sorting accuracy, accelerating diagnostics, and informing clinical decisions. This review synthesizes the convergence of microfluidics and machine intelligence, examining their synergistic roles in flow-field optimization, cellular classification, and error correction. While highlighting breakthroughs in diagnostic sensitivity and analytical throughput, we critically address challenges including model generalizability and hardware-software integration. Last, we provide an outlook on multimodal data fusion and the development of on-chip intelligent systems, proposing a roadmap for advancing precision medicine through embedded, adaptive biosensing platforms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.